Funding
← Back to your selection

Alexandria Venture Investments

Activity from announced rounds

Activity in this selectionUnited States · Oct 14, 2026 · Jul 17, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$80M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Leal Therapeutics

Develops neuro-metabolic therapeutics for schizophrenia and ALS

$30MSeries A
Role not disclosed
Khartis Therapeutics

Develops oral small molecule therapies for immunological and chronic diseases

$50MSeries B
Role not disclosed